PACER: Locally Advanced Pancreatic Cancer: Phase II study of Cetuximab and 3-D Conformal image guided Radiotherapy.
Phase of Trial: Phase II
Latest Information Update: 28 Jul 2016
At a glance
- Drugs Cetuximab (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Acronyms PACER
- 29 Jun 2011 Additional lead investigator added as reported United Kingdom Clinical Research Network record.
- 09 Oct 2010 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 09 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.